More than 10 percent of cases of recurrent ductal carcinoma in situ (DCIS) of the breast were "de novo" tumors that occurred independently of the primary lesion and had distinct genetic alterations, according to data presented ...
Apr 10, 2022
0
7
Adding an anti-inflammatory medication to immunotherapy and standard chemotherapy drugs may provide long-term suppression of aggressive bladder tumor growth, according to a proof-of-concept study led by Cedars-Sinai Cancerinvestigators. ...
Mar 28, 2022
0
88
Open surgery for radical hysterectomy offers early-stage cervical cancer patients a lower recurrence rate and a higher disease-free survival rate at 4.5 years than a minimally invasive surgical approach, according to the ...
Mar 25, 2022
0
4
Long-term survival data from the first prospective, randomized biomarker validation trial in patients with muscle-invasive bladder cancer being treated with cisplatin-based chemotherapy before surgery will be reported at ...
Feb 14, 2022
0
6
Findings from a new study led by Yale Cancer Center researchers show enfortumab vedotin is effective in patients with muscle-invasive bladder cancer (MIBC) not eligible for cisplatin chemotherapy. The data is from Cohort ...
Feb 14, 2022
0
24
(HealthDay)—Women with, versus without, a history of breast cancer have a higher incidence of hypertension and diabetes up to 10 years following diagnosis, according to a study published online Jan. 13 in the Journal of ...
Jan 20, 2022
0
26
National and international guidelines call for administration of postoperative immediate chemotherapy to reduce recurrence of non-muscle invasive bladder cancer. Yet this is done in less than half of cases. A new study ...
Nov 16, 2021
0
6
Regular blood tests before and during chemotherapy for prostate cancer can detect whether or not a patient is resistant or developing resistance to treatment with docetaxel, according to research presented at the NCRI Festival.
Nov 10, 2021
0
1
The membranes of cancer cells are more pliant than the membranes of normal cells. A research collaboration has discovered that cancer invasion and migration can be supressed in mice by manipulating the stiffness of the cell ...
Nov 8, 2021
0
1
Oral malignancies represent the seventh-most common cancer worldwide. Many diagnosed patients relapse, despite radical resection of the primary oral squamous cell carcinoma (OSCC) lesion. Therefore, understanding the local ...
Oct 25, 2021
0
0
